The actor was diagnosed eight years ago, according to his caretaker.

FDA gives go-ahead to D1/D5 dopamine agonist tavapadon ...

Sept 25 (Reuters) - The US Food and Drug Administration has approved AbbVie's treatment for Parkinson's disease in adults, ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first ...

A recent study from CSIR-CCMB reveals how viral infections may trigger amyloid formation leading to Parkinson's disease.

A new study by CSIR-CCMB researchers has elucidated the molecular mechanisms by which viral infections, particularly RNA viruses like Influenza and COVID-19, can accelerate the formation of amyloid ...

Basic knowledge for "treating the whole body," not just motor symptomsWhen you hear Parkinson's disease, you might first think of "hand tremors" or "difficulty walking." However, the important point ...

A new study by scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad has revealed how viral ...

HYDERABAD: A study by researchers at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, has identified a ...

New information is emerging about Dennis Haskins‘ health following his death at 75. Kimberly Snow, a friend and caretaker of the Saved by the Bell alum, told The New York Times following news of his ...

Juvmo (tavapadon) offers a novel, selective D1/D5 dopamine receptor partial agonist mechanism for early monotherapy and adjunctive treatment in Parkinson disease.

AbbVie ( ABBV) announced that the U.S. FDA has approved JUVMO (tavapadon) tablets for the treatment of adults with Parkinson's disease, providing a new oral treatment option for a progressive ...